Review



pax7 ab 528428 myod mouse igg2b  (Developmental Studies Hybridoma Bank)


Bioz Verified Symbol Developmental Studies Hybridoma Bank is a verified supplier
Bioz Manufacturer Symbol Developmental Studies Hybridoma Bank manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Developmental Studies Hybridoma Bank pax7 ab 528428 myod mouse igg2b
    Pax7 Ab 528428 Myod Mouse Igg2b, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 2474 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pax7 ab 528428 myod mouse igg2b/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 2474 article reviews
    pax7 ab 528428 myod mouse igg2b - by Bioz Stars, 2026-05
    99/100 stars

    Images



    Similar Products

    99
    Developmental Studies Hybridoma Bank pax7 ab 528428 myod mouse igg2b
    Pax7 Ab 528428 Myod Mouse Igg2b, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pax7 ab 528428 myod mouse igg2b/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    pax7 ab 528428 myod mouse igg2b - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse anti myod monoclonal antibody
    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of <t>MyoD</t> and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm
    Mouse Anti Myod Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti myod monoclonal antibody/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse anti myod monoclonal antibody - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology pax7 ab 528428 myod mouse igg2b
    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of <t>MyoD</t> and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm
    Pax7 Ab 528428 Myod Mouse Igg2b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pax7 ab 528428 myod mouse igg2b/product/Santa Cruz Biotechnology
    Average 95 stars, based on 1 article reviews
    pax7 ab 528428 myod mouse igg2b - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank mouse anti myod
    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of <t>MyoD</t> and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm
    Mouse Anti Myod, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti myod/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse anti myod - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse monoclonal anti myod
    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of <t>MyoD</t> and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm
    Mouse Monoclonal Anti Myod, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti myod/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse monoclonal anti myod - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse anti myod
    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of <t>MyoD</t> and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm
    Mouse Anti Myod, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti myod/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse anti myod - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse anti myogenic differentiation antigen myod
    Proliferation of C2C12 cells on AG/PDA gel scaffold. a) Representative images of C2C12 cells stained with EdU incorporation assay on AG/PDA gel scaffolds, b) EdU positive cells of C2C12 cells were evaluated (n = 6). The PDA coating has optical absorption properties, color codes: blue: nuclei; red: EdU, multicolor: merge, bars: 100 μm. c) Western blot analysis of <t>MYOD</t> and GADPH protein levels in the proliferative and differentiation phases (n = 3). d ) Quantification of MYOD expression normalized <t>to</t> <t>GAPDH</t> from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01 and *** p < 0.001, ns: not significant).
    Mouse Anti Myogenic Differentiation Antigen Myod, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti myogenic differentiation antigen myod/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse anti myogenic differentiation antigen myod - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of MyoD and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm

    Journal: Skeletal Muscle

    Article Title: TRPV1 manipulating polarization of M1/M2 macrophages to promote skeletal muscle regeneration

    doi: 10.1186/s13395-026-00417-6

    Figure Lengend Snippet: Activation of TRPV1 facilitates myogenesis during the process of muscle regeneration in vivo. A-C Representative western blot and relative protein level of MyoD and myogenin in CTX-induced muscle tissue after treatment with CAP and CPZ at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). D , F The expression level of MyoD and myogenin mRNA in each group at different points in time ( n = 3 animals per experimental group; mean ± SD; Two-way ANOVA). E Representative immunofluorescence images of MyoD in CTX-induced muscle tissue after treatment with CAP and CPZ at 4d. G-H The relative fluorescence intensity of MyoD and the proportion of MyoD+ /DAPI + double-positive cells in each group ( n = 5 animals per experimental group; mean ± SD; One-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm

    Article Snippet: Deparaffinized sections were blocked with 5% bovine serum albumin (BSA) and incubated overnight at 4 °C with the following primary antibodies: mouse anti-CD86 monoclonal antibody (1:200, Santa Cruz Biotechnology, sc-28347); mouse anti-CD206 polyclonal antibody (1:200, Santa Cruz Biotechnology, sc-58986); rat anti-F4/80 monoclonal antibody (1:100, Abcam, ab1691); rabbit anti-F4/80 monoclonal antibody (1:200, Proteintech, #27044-1-AP); rabbit anti-TRPV1 polyclonal antibody (1:200, ABclonal, A8564); and mouse anti-MyoD monoclonal antibody (1:100, Santa Cruz Biotechnology, sc-377460).

    Techniques: Activation Assay, In Vivo, Western Blot, Expressing, Immunofluorescence, Fluorescence

    The influence of TRPV1 in the C2C12 myoblasts differentiation. A-C The relative fluorescence intensity of TRPV1( n = 5 independent random fields of cells; mean ± SD; One-way ANOVA). D Representative western blot of TRPV1 after treatment with CAP and CPZ in vitro. E The protein expression of TRPV1 ( n = 3 independent replicates in cells; mean ± SD; One-way ANOVA). F Representative western blot of MyoD and myogenin after treatment with CAP and CPZ in differentiation medium at different intervals. G , H The protein expression of MyoD and myogenin among each group ( n = 3 independent replicates in cells; mean ± SD; Two-way ANOVA). I , J The relative fluorescence intensity of MYH3 in multinucleated myotubes in each group time-dependently ( n = 5 independent random fields of cells; mean ± SD; Two-way ANOVA). K Representative Giemsa staining images showed the effect of TRPV1 activation individually on multinucleated myotubes ( n = 5 independent random fields of cells). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm, 100 μm

    Journal: Skeletal Muscle

    Article Title: TRPV1 manipulating polarization of M1/M2 macrophages to promote skeletal muscle regeneration

    doi: 10.1186/s13395-026-00417-6

    Figure Lengend Snippet: The influence of TRPV1 in the C2C12 myoblasts differentiation. A-C The relative fluorescence intensity of TRPV1( n = 5 independent random fields of cells; mean ± SD; One-way ANOVA). D Representative western blot of TRPV1 after treatment with CAP and CPZ in vitro. E The protein expression of TRPV1 ( n = 3 independent replicates in cells; mean ± SD; One-way ANOVA). F Representative western blot of MyoD and myogenin after treatment with CAP and CPZ in differentiation medium at different intervals. G , H The protein expression of MyoD and myogenin among each group ( n = 3 independent replicates in cells; mean ± SD; Two-way ANOVA). I , J The relative fluorescence intensity of MYH3 in multinucleated myotubes in each group time-dependently ( n = 5 independent random fields of cells; mean ± SD; Two-way ANOVA). K Representative Giemsa staining images showed the effect of TRPV1 activation individually on multinucleated myotubes ( n = 5 independent random fields of cells). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm, 100 μm

    Article Snippet: Deparaffinized sections were blocked with 5% bovine serum albumin (BSA) and incubated overnight at 4 °C with the following primary antibodies: mouse anti-CD86 monoclonal antibody (1:200, Santa Cruz Biotechnology, sc-28347); mouse anti-CD206 polyclonal antibody (1:200, Santa Cruz Biotechnology, sc-58986); rat anti-F4/80 monoclonal antibody (1:100, Abcam, ab1691); rabbit anti-F4/80 monoclonal antibody (1:200, Proteintech, #27044-1-AP); rabbit anti-TRPV1 polyclonal antibody (1:200, ABclonal, A8564); and mouse anti-MyoD monoclonal antibody (1:100, Santa Cruz Biotechnology, sc-377460).

    Techniques: Fluorescence, Western Blot, In Vitro, Expressing, Staining, Activation Assay

    TRPV1 regulates M1/M2 macrophage polarization to promote myogenic differentiation in C2C12 cells. A C2C12 myoblasts were co-cultured with M1 or M2 macrophages for 4 days via a transwell cell culture insert. B Representative Western blot bands of MyoD and MYH3 in C2C12 myoblasts after being co-cultured with M1 or M2 macrophages for 4 days. C , D The protein expression of MyoD and MYH3 in those C2C12 myoblasts which were co-cultured with M1or M2 macrophages after CAP and CPZ treatment ( n = 3 independent replicates in cells; mean ± SD; Two-way ANOVA). E , F Representative immunofluorescence images showed myotubes fusion index in C2C12 cells ( n = 5 independent random fields of cells; mean ± SD; Two-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm

    Journal: Skeletal Muscle

    Article Title: TRPV1 manipulating polarization of M1/M2 macrophages to promote skeletal muscle regeneration

    doi: 10.1186/s13395-026-00417-6

    Figure Lengend Snippet: TRPV1 regulates M1/M2 macrophage polarization to promote myogenic differentiation in C2C12 cells. A C2C12 myoblasts were co-cultured with M1 or M2 macrophages for 4 days via a transwell cell culture insert. B Representative Western blot bands of MyoD and MYH3 in C2C12 myoblasts after being co-cultured with M1 or M2 macrophages for 4 days. C , D The protein expression of MyoD and MYH3 in those C2C12 myoblasts which were co-cultured with M1or M2 macrophages after CAP and CPZ treatment ( n = 3 independent replicates in cells; mean ± SD; Two-way ANOVA). E , F Representative immunofluorescence images showed myotubes fusion index in C2C12 cells ( n = 5 independent random fields of cells; mean ± SD; Two-way ANOVA). Statistical significance was set at P < 0.05. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Scale bar, 50 μm

    Article Snippet: Deparaffinized sections were blocked with 5% bovine serum albumin (BSA) and incubated overnight at 4 °C with the following primary antibodies: mouse anti-CD86 monoclonal antibody (1:200, Santa Cruz Biotechnology, sc-28347); mouse anti-CD206 polyclonal antibody (1:200, Santa Cruz Biotechnology, sc-58986); rat anti-F4/80 monoclonal antibody (1:100, Abcam, ab1691); rabbit anti-F4/80 monoclonal antibody (1:200, Proteintech, #27044-1-AP); rabbit anti-TRPV1 polyclonal antibody (1:200, ABclonal, A8564); and mouse anti-MyoD monoclonal antibody (1:100, Santa Cruz Biotechnology, sc-377460).

    Techniques: Cell Characterization, Cell Culture, Western Blot, Expressing, Immunofluorescence

    Proliferation of C2C12 cells on AG/PDA gel scaffold. a) Representative images of C2C12 cells stained with EdU incorporation assay on AG/PDA gel scaffolds, b) EdU positive cells of C2C12 cells were evaluated (n = 6). The PDA coating has optical absorption properties, color codes: blue: nuclei; red: EdU, multicolor: merge, bars: 100 μm. c) Western blot analysis of MYOD and GADPH protein levels in the proliferative and differentiation phases (n = 3). d ) Quantification of MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01 and *** p < 0.001, ns: not significant).

    Journal: Journal of Advanced Research

    Article Title: Versatile platforms of mussel-inspired agarose scaffold for cell cultured meat

    doi: 10.1016/j.jare.2025.01.024

    Figure Lengend Snippet: Proliferation of C2C12 cells on AG/PDA gel scaffold. a) Representative images of C2C12 cells stained with EdU incorporation assay on AG/PDA gel scaffolds, b) EdU positive cells of C2C12 cells were evaluated (n = 6). The PDA coating has optical absorption properties, color codes: blue: nuclei; red: EdU, multicolor: merge, bars: 100 μm. c) Western blot analysis of MYOD and GADPH protein levels in the proliferative and differentiation phases (n = 3). d ) Quantification of MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01 and *** p < 0.001, ns: not significant).

    Article Snippet: After sealing the membranes with 5 % bovine serum albumin buffer for 2 h at room temperature, the membranes were incubated at 4 °C overnight with primary antibodies ((rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Abcam, ab181602, 1:10000), mouse anti- myogenic differentiation antigen (MyoD) (Santa Cruz Biotechnology, sc-377460, 1:500), primary MYHC antibody (1:500), then secondary antibodies (horseradish peroxidase (HRP)-conjugated goat anti-rabbit (Beyotime, A208,1:1000), HRP-conjugated goat anti-mouse antibody (Beyotime, A216, 1:1000) was incubated for 1 h at room temperature.

    Techniques: Staining, Western Blot, Expressing

    Myogenesis of PSMSCs on AG/PDA gel scaffold. a) Representative photographic images of PMSCs were first adhesion after inoculation on AG/PDA gel scaffolds for two hours. b) Adhesion ratio of PSMSCs on AG/PDA gel scaffolds (n = 6). c) Representative images of PSMSCs stained with EdU incorporation assay on AG/PDA gel scaffolds. d) EdU positive cells of PSMSCs were evaluated (n = 6). The PDA coating has optical absorption properties, color codes: blue: nuclei; red: EdU, multicolor: merge, bars: 50 μm. e) the metabolic activity of PSMSCs with alma blue cell viability assay on AG/PDA gel scaffolds (n = 6). f) Representative images of immunofluorescent stained PSMSCs and myotubes after 5 days of differentiation on AG/PDA gel scaffolds. Color codes: blue: nuclei, red: MYHC, green: phalloidin, multicolor: merge, bars: 50 μm. g) Western blot analysis of MYHC, MYOD, and GAPDH protein levels in the proliferative and differentiation phases (n = 3). h) Quantification of MYHC and MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001, ns: not significant).

    Journal: Journal of Advanced Research

    Article Title: Versatile platforms of mussel-inspired agarose scaffold for cell cultured meat

    doi: 10.1016/j.jare.2025.01.024

    Figure Lengend Snippet: Myogenesis of PSMSCs on AG/PDA gel scaffold. a) Representative photographic images of PMSCs were first adhesion after inoculation on AG/PDA gel scaffolds for two hours. b) Adhesion ratio of PSMSCs on AG/PDA gel scaffolds (n = 6). c) Representative images of PSMSCs stained with EdU incorporation assay on AG/PDA gel scaffolds. d) EdU positive cells of PSMSCs were evaluated (n = 6). The PDA coating has optical absorption properties, color codes: blue: nuclei; red: EdU, multicolor: merge, bars: 50 μm. e) the metabolic activity of PSMSCs with alma blue cell viability assay on AG/PDA gel scaffolds (n = 6). f) Representative images of immunofluorescent stained PSMSCs and myotubes after 5 days of differentiation on AG/PDA gel scaffolds. Color codes: blue: nuclei, red: MYHC, green: phalloidin, multicolor: merge, bars: 50 μm. g) Western blot analysis of MYHC, MYOD, and GAPDH protein levels in the proliferative and differentiation phases (n = 3). h) Quantification of MYHC and MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001, ns: not significant).

    Article Snippet: After sealing the membranes with 5 % bovine serum albumin buffer for 2 h at room temperature, the membranes were incubated at 4 °C overnight with primary antibodies ((rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Abcam, ab181602, 1:10000), mouse anti- myogenic differentiation antigen (MyoD) (Santa Cruz Biotechnology, sc-377460, 1:500), primary MYHC antibody (1:500), then secondary antibodies (horseradish peroxidase (HRP)-conjugated goat anti-rabbit (Beyotime, A208,1:1000), HRP-conjugated goat anti-mouse antibody (Beyotime, A216, 1:1000) was incubated for 1 h at room temperature.

    Techniques: Staining, Activity Assay, Viability Assay, Western Blot, Expressing

    Myogenesis of PSMSCs on AG/PDA film scaffold. a) Schematic of the production process of film scaffolds. b) Representative SEM images of the PDA particles on film scaffold, bar: 1 μm. c) Analysis of the surface hydrophilic angle on film scaffolds (n = 3). d) Representative images of surface hydrophilic angles of film scaffolds and Water absorption swelling rate of film scaffolds (n = 3). e) Representative SEM images of the AG/PDA-0.2 film scaffold surface with and without PSMSCs adhesion, bar: 1 μm. f) the metabolic activity of PSMSCs with alma blue cell viability assay on AG/PDA film scaffolds (n = 6). g) Representative 3D reconstruction images of immunofluorescent stained PSMSCs and myotubes after 5 days differentiation on AG/PDA film scaffolds. Color codes: blue: nuclei, red: MYHC, green: phalloidin, multicolor: merge, bars: 150 μm. h) Western blot analysis of MYHC, MYOD, and GAPDH protein levels in the proliferative and differentiation phases (n = 3). i) Quantification of MYHC and MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001, ns: not significant).

    Journal: Journal of Advanced Research

    Article Title: Versatile platforms of mussel-inspired agarose scaffold for cell cultured meat

    doi: 10.1016/j.jare.2025.01.024

    Figure Lengend Snippet: Myogenesis of PSMSCs on AG/PDA film scaffold. a) Schematic of the production process of film scaffolds. b) Representative SEM images of the PDA particles on film scaffold, bar: 1 μm. c) Analysis of the surface hydrophilic angle on film scaffolds (n = 3). d) Representative images of surface hydrophilic angles of film scaffolds and Water absorption swelling rate of film scaffolds (n = 3). e) Representative SEM images of the AG/PDA-0.2 film scaffold surface with and without PSMSCs adhesion, bar: 1 μm. f) the metabolic activity of PSMSCs with alma blue cell viability assay on AG/PDA film scaffolds (n = 6). g) Representative 3D reconstruction images of immunofluorescent stained PSMSCs and myotubes after 5 days differentiation on AG/PDA film scaffolds. Color codes: blue: nuclei, red: MYHC, green: phalloidin, multicolor: merge, bars: 150 μm. h) Western blot analysis of MYHC, MYOD, and GAPDH protein levels in the proliferative and differentiation phases (n = 3). i) Quantification of MYHC and MYOD expression normalized to GAPDH from western blot gel (n = 3). Data presented as mean ± SD (* p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001, ns: not significant).

    Article Snippet: After sealing the membranes with 5 % bovine serum albumin buffer for 2 h at room temperature, the membranes were incubated at 4 °C overnight with primary antibodies ((rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Abcam, ab181602, 1:10000), mouse anti- myogenic differentiation antigen (MyoD) (Santa Cruz Biotechnology, sc-377460, 1:500), primary MYHC antibody (1:500), then secondary antibodies (horseradish peroxidase (HRP)-conjugated goat anti-rabbit (Beyotime, A208,1:1000), HRP-conjugated goat anti-mouse antibody (Beyotime, A216, 1:1000) was incubated for 1 h at room temperature.

    Techniques: Activity Assay, Viability Assay, Staining, Western Blot, Expressing